U.K. Pharmaceuticals & Biotech Most Popular Stocks

AstraZeneca

Market Cap: UK£210.6b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£78.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Haleon

Market Cap: UK£29.6b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Hikma Pharmaceuticals

Market Cap: UK£3.2b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

HUTCHMED (China)

Market Cap: UK£1.5b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Genus

Market Cap: UK£1.5b

Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.

Oxford Nanopore Technologies

Market Cap: UK£1.2b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.

Oxford Biomedica

Market Cap: UK£737.6m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Allergy Therapeutics

Market Cap: UK£506.6m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.

Avacta Group

Market Cap: UK£320.8m

Engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.

PureTech Health

Market Cap: UK£310.6m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Animalcare Group

Market Cap: UK£228.9m

Develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally.

Scancell Holdings

Market Cap: UK£194.6m

A clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom.

Diaceutics

Market Cap: UK£120.7m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Faron Pharmaceuticals Oy

Market Cap: UK£88.3m

Operates as a clinical stage drug discovery and development company.

4basebio

Market Cap: UK£81.3m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

Bioventix

Market Cap: UK£81.0m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Shield Therapeutics

Market Cap: UK£66.2m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

ECO Animal Health Group

Market Cap: UK£62.3m

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.

hVIVO

Market Cap: UK£57.0m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Poolbeg Pharma

Market Cap: UK£54.3m

A clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom.

Hemogenyx Pharmaceuticals

Market Cap: UK£52.4m

A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer in the United Kingdom and the United States.

Coiled Therapeutics

Market Cap: UK£44.7m

A clinical-stage oncology company, develops and commercialises clinical-stage oncology therapeutics in the United Kingdom and internationally.

Sareum Holdings

Market Cap: UK£31.9m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

ImmuPharma

Market Cap: UK£28.5m

A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.

Arecor Therapeutics

Market Cap: UK£24.5m

A clinical stage biotechnology company, develops therapeutics that address diabetes, obesity and other cardiometabolic diseases in the United Kingdom.

Palatin Technologies

Market Cap: US$25.4m

A biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.

genedrive

Market Cap: UK£18.9m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

IXICO

Market Cap: UK£18.9m

Provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally.

Aptamer Group

Market Cap: UK£18.1m

Provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

SkinBioTherapeutics

Market Cap: UK£16.8m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

Fusion Antibodies

Market Cap: UK£15.3m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

ProBiotix Health

Market Cap: UK£14.2m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

Solvonis Therapeutics

Market Cap: UK£13.6m

A clinical-stage biopharmaceutical company, develops medicines for addiction, psychiatry, and neurology disorders.

Genflow Biosciences

Market Cap: UK£12.2m

Engages in the research and development of gene therapies in the United Kingdom, Belgium, and the United States.

Cizzle Biotechnology Holdings

Market Cap: UK£11.7m

Operates as a cancer diagnostics company in the United Kingdom.